-transparent.png){kind=logo}
A comparative study of the oto- and nephrotoxicity of amikacin and gentamicin was carried out prospectively. Twenty-six gentamicin-treated patients and 27 amikacin-treated patients were monitored for changes in auditory and renal function during and after therapy. Thirteen of those treated with gentamicin and 20 of those treated with amikacin underwent vestibular caloric testing which could be evaluated for evidence of toxicity. In four (15.4%) of the gentamicin-treated patients, nephrotoxicity developed; no such toxicity was seen in the amikacin-treated patients. This difference may have been due to a fortuitously higher incidence of pretreatment renal impairment in the gentamicin-treated group. In two gentamicin-treated patients (7.7%), ototoxicity developed (one auditory, one vestibular), and in two amikacin-treated patients (7.4%), auditory toxicity developed. Statistical analysis of oto- and nephrotoxicity and their risk factors was not attempted because of the small numbers of patients who could be evaluated. Additional patients are being studied.
S A Lerner, and
R Seligsohn, and
G J Matz
August 1977,
Antimicrobial agents and chemotherapy,
S A Lerner, and
R Seligsohn, and
G J Matz
January 1979,
Infection,
S A Lerner, and
R Seligsohn, and
G J Matz
January 1987,
Drugs under experimental and clinical research,
S A Lerner, and
R Seligsohn, and
G J Matz
May 1977,
The New England journal of medicine,
S A Lerner, and
R Seligsohn, and
G J Matz
September 1982,
Toxicology and applied pharmacology,
S A Lerner, and
R Seligsohn, and
G J Matz
January 2016,
Nigerian medical journal : journal of the Nigeria Medical Association,
S A Lerner, and
R Seligsohn, and
G J Matz
March 1978,
The Johns Hopkins medical journal,
S A Lerner, and
R Seligsohn, and
G J Matz
August 1976,
The Journal of infectious diseases,
S A Lerner, and
R Seligsohn, and
G J Matz
October 1985,
Cahiers d'anesthesiologie,
S A Lerner, and
R Seligsohn, and
G J Matz
January 1978,
Arzneimittel-Forschung,
